RFX2 inhibitors constitute a class of chemical compounds that have garnered interest in the field of molecular biology and transcriptional regulation research. These inhibitors are specifically designed to target and modulate the activity of RFX2, which stands for Regulatory Factor X 2. RFX2 is a transcription factor known for its role in controlling gene expression by binding to specific DNA sequences within the promoter regions of target genes. It belongs to the Regulatory Factor X (RFX) family, which is involved in regulating various cellular processes, including the development and function of cilia, a hair-like structure on the surface of cells with critical roles in signaling and motility.
RFX2 inhibitors exert their effects by interfering with the DNA-binding capacity or transcriptional activity of RFX2, disrupting its role in gene regulation. This interference can lead to alterations in the expression of downstream target genes, influencing cellular processes that rely on the precise control of gene expression, including ciliogenesis and cilium-related functions. Researchers employ RFX2 inhibitors as valuable tools to investigate the specific roles of RFX2 in different cellular contexts and to better understand the molecular mechanisms governing transcriptional regulation and cilia-related processes. While the precise applications and broader implications of RFX2 inhibitors continue to be subjects of ongoing research, their utility in unraveling the complexities of gene expression and its impact on cellular physiology is of paramount importance in advancing our understanding of molecular and cell biology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A inhibits histone deacetylases (HDACs), which may result in altered chromatin structure and reduced RFX2 transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine inhibits DNA methyltransferases, potentially causing hypomethylation and affecting RFX2 gene expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A binds to GC-rich DNA sequences, possibly inhibiting the binding of transcription factors to RFX2 promoter regions. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D intercalates into DNA, inhibiting RNA polymerase and potentially decreasing RFX2 mRNA synthesis. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide has been shown to inhibit transcriptional activity, which could lead to reduced expression of RFX2. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat is an HDAC inhibitor that may cause chromatin remodeling and downregulation of RFX2 expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Decitabine is another DNA methyltransferase inhibitor, which could lead to changes in RFX2 gene expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Alpha-amanitin inhibits RNA polymerase II, and could thereby reduce RFX2 mRNA levels. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
JQ1 inhibits BET bromodomain proteins, which may result in altered expression of genes like RFX2. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG108 is a non-nucleoside DNA methyltransferase inhibitor, which might impact the methylation status of RFX2 promoter regions. | ||||||